Press release
Invite from the Chairman Hugues Malonne at SMI’s 5th Annual Molecular Diagnostics Conference
SMi proudly presents Hugues Malonne, Director General, DG POST authorisation, Federal Agency for Medicines and Health Products, as one of the chairs for the 5th Molecular Diagnostics conference, which will focus on evaluating the future of diagnostics for rapid detection and improved clinical outcomes. The event will take place at the Holiday Inn Kensington Forum, London, UK on 9th and 10th July 2018, with a half-day post-conference workshop on 11th July 2018.Mr Malonne, who is co-chairing the two-day conference with David Crosby, Cancer Research, UK, has stated ‘As the co-chair for the event, I am particularly interested in you joining us to discuss the role of molecular diagnosis in the devolvement of personalised medicine, analyse the latest developments in companion diagnostics and discuss the future of the industry, learn what will be required in the new European In Vitro Diagnostics Regulations, assess opportunities and novel diagnostics technologies at the point-of-care, plus much more’.
On day one of the conference, Mr Malonne will be giving a presentation on ‘A National Competent Authority’s perspective on IVDR implementation’, where he will be discussing how the transition to IVDR can be supported and how to address the upcoming challenges associated.
The two-day event will feature over 16 presentations from highly-regarded, expert speakers hailing from big pharma companies, charities and medical institutions such as AstraZeneca, Cancer Research UK, Genentech and many more. The presentations will explore various topics on compliance with regulations across the globe, developing diagnostics, opportunities in point of care testing advancements in personalised medicine and much more.
Book by the 30th April to receive a £200 discount.
For the full agenda and speaker line-up, visit the website to download the brochure at www.molecular-diagnostics-conference.com/PR2
________________________________________
Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk
________________________________________
For media enquiries, contact Simi Sapal, Marketing on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk
Molecular Diagnostics
9th – 10th July 2018
Holiday Inn Kensington Forum, London, UK
www.molecular-diagnostics-conference.com/PR2
Follow us @SMiPharm
#SMiMolecularDx
---- END ----
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
1st Floor
1 Westminster Bridge Road
London
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Invite from the Chairman Hugues Malonne at SMI’s 5th Annual Molecular Diagnostics Conference here
News-ID: 1032319 • Views: …
More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…

Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…

FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Molecular
Molecular Breeding Market Report 2024 - Molecular Breeding Market Size, Share An …
"The Business Research Company recently released a comprehensive report on the Global Molecular Breeding Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The molecular breeding market size…
Molecular Quality Controls: Ensuring Precision and Reliability in Molecular Diag …
Introduction
Molecular quality controls (MQCs) play a critical role in molecular diagnostics, helping laboratories and healthcare providers ensure the accuracy, reliability, and consistency of diagnostic tests. These quality controls are essential in detecting and monitoring infectious diseases, genetic disorders, cancer biomarkers, and other molecular targets. By providing standards that verify the performance of diagnostic assays, MQCs help reduce errors, minimize false results, and maintain compliance with regulatory standards. As the demand…
Molecular Diagnostic Platform Market Advancing Molecular Diagnostics with Innova …
Global Molecular Diagnostic Platform Market Overview:
The Molecular Diagnostic Platform market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Molecular Diagnostic Platform market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
Molecular Modeling Market - Visualizing the unseen: Molecular modeling for grou …
Newark, New Castle, USA: The "Molecular Modeling Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Molecular Modeling Market: https://www.growthplusreports.com/report/molecular-modeling-market/8615
This latest report researches the industry structure, sales, revenue,…
Molecular Diagnostics Market - Empowering healthcare through molecular precision …
Newark, New Castle, USA: The "Molecular Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Molecular Diagnostics Market: https://www.growthplusreports.com/report/molecular-diagnostics-market/7674
This latest report researches the industry structure, sales, revenue,…
Molecular Imaging Device Market scenario for 2022 | Trivitron Healthcare, Molecu …
The Molecular Imaging Device market report anticipate the market growth and recent developments in market competition which helps players to strategies and analysis the position in Molecular Imaging Device market. It also indicates the risk factors, advancements, market drivers, revenue, business scenario, growth potential, market scope, new trends, and historical data of Molecular Imaging Device market. With this futuristic approach researchers also provides a close study of market forecast, overview…